Formulation and Evaluation of Liposomal Based Nanocochleate
DOI:
https://doi.org/10.22270/ajprd.v12i4.1435Abstract
Rivastigmine is a parasympathomimetics and a reversible cholinesterase inhibitor. It inhibits both acetylcholinesterase and butylcholinesterase. It is used to treat mild to moderate dementia caused by Alzheimer's or Parkinson's disease. However, its bioavailability is about 36% due to hepatic first-pass metabolism. The plasma half-life of rivastigmine is approximately 1.5 hours. Rivastigmine tartrate-loaded nanococclets (RN) were developed using a trapping method by addition of calcium ions to preformed negatively charged liposomes (RL) prepared by thin film hydration method. Liposomes were optimized by varying the concentrations of disteroylphosphodylcholine (DSPC) and cholesterol. The optimized liposomal batch (RL) containing DSPC (40mg) and cholesterol (10mg) showed mean particle size, zeta potential and entrapment of 112 ± 4 nm, -51.70 ± 7.3 mV and 99.6 ± 4 % for the final form, 51.70 ± 7.3 mV. Observed with efficiency. RN3 which was developed from RL showed 631.4 ± 4 nm, -17 ± 6.5 mV and 99 ± 4.20 %. Encapsulation of RT in nanocochleates is to protect the drug from rapid metabolism, thereby improving bioavailability and ensuring controlled release. In vitro drug release studies showed extended release up to 24 hours, reduced dosing frequency compared to plain drug formulation, nearly 100% of drug was released within 8 hours from pure RT solution, while powder nanococclets released 69% of drug. 8 hours respectively. Stability studies also concluded that nanocochleates are more stable than liposomes.
Downloads
References
Pawar SF, Bothara SS, Mahaparale PR, Musale VL. Nanocochleate–An Important Drug Delivery System Offering Unique Features. World J. Pharm. Res. 2020 Jul 2; 9(9):621-37.
Panda P, De M, Basak S. Nanocochleates: A novel lipid-based nanocarrier system for drug delivery. InDesign and Applications of Theranostic Nanomedicines 2023; 1:143-173. Woodhead Publishing.
Talke S, Salunkhe K, Chavan MA, Hundiwale JC, Harwalkar M, Waykar M. Review on nanocochleates novel approach for drug delivery. World J. Pharm. Pharm. Sci. 2018; 7(7):284-94.
Tilawat M, Bonde S. Nanocochleates: A potential drug delivery system. Journal of Molecular Liquids. 2021 Jul 15; 334:116115.
Gauthreaux K, Bonnett TA, Besser LM, Brenowitz WD, Teylan M, Mock C, Chen YC, Chan KC, Keene CD, Zhou XH, Kukull WA. Concordance of clinical Alzheimer diagnosis and neuropathological features at autopsy. Journal of Neuropathology & Experimental Neurology. 2020 May 1; 79(5):465-73.
Rosler M. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial (vol 318, pg 633, 1999). British Medical Journal. 2001 Jun 16; 322(7300):1456-.
Shamsi A, Anwar S, Mohammad T, Alajmi MF, Hussain A, Rehman MT, Hasan GM, Islam A, Hassan MI. MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: Insights into Alzheimer’s disease therapy. Biomolecules. 2020 May 20;10(5):789.
Aulton ME, Taylor K. Pharmaceutical preformulation. Aulton’s pharmaceutics: The design and manufacture of medicines.(4thedn), Elsevie r Health Sciences, Edinburgh. 2013.
Sakore S, Choudhari S, Chakraborty BH. Biowaiver monograph for immediate release solid oral dosage forms: ofloxacin. Int J Pharm Pharm Sci. 2010; 2(Suppl 4):156-61.
Tapkir N, Soni F, Sahu AK, Jadav T, Tekade RK, Sengupta P. A comprehensive review on assessment and key control strategies for impurities in drug development with a special emphasis on post-marketing surveillance. Journal of Pharmaceutical Innovation. 2021:1-20.
Part SN. Bachelor of Science B. Sc. Chemistry Degree Course (With effect from 2020-2021) The Course of Study and the Scheme of Examinations.
Sharmila SK, Srilakshimi M, Renukadevi G, Rahaman SA, Shanthakumari K. Development and validation of UV-spectrophotometric method for the estimation of rivastigmine tartrate in bulk and pharmaceutical dosage form. Indo American Journal of Pharmaceutical Research. 2013;3(10):8394-9.
Rothery, Mark. "Techniques: Biochemical Tests". Mark Rothery's Biology Web Site. Wikipedia.
Williams JH, Kuchmak M, Witter RF. Purity of cholesterol to be used as a primary standard. Journal of Lipid Research. 1965 Oct 1; 6(4):461-5.
H.W. Hanna and A. Dittmar; Laboratory Manual for General Chemistry, 4th ed.; Morton Publishing Company, Denver, Colorado.
Craparo EF, Pitarresi G, Bondì ML, Casaletto MP, Licciardi M, Giammona G. A nanoparticulate drug‐delivery system for rivastigmine: physico‐chemical and in vitro biological characterization. Macromolecular bioscience. 2008 Mar 10; 8(3):247-59.
Delmarre D, Lu R, Tatton N, Krause-Elsmore S, Gould-Fogerite S, Mannino RJ. Formulation of hydrophobic drugs into cochleate delivery vehicles: A simplified protocol & formulation kit. Drug delivery technology. 2004; 4(1):64-9.
Bothiraja C, Rajput N, Poudel I, Rajalakshmi S, Panda B, Pawar A. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform. Artificial cells, nanomedicine, and biotechnology. 2018 Oct 31; 46(sup1):447-61.
Asprea M, Leto I, Bergonzi MC, Bilia AR. Thyme essential oil loaded in nanocochleates: Encapsulation efficiency, in vitro release study and antioxidant activity. LWT. 2017 Apr 1; 77:497-502.
Shanmugam T, Joshi N, Kaviratna A, Ahamad N, Bhatia E, Banerjee R. Aerosol delivery of paclitaxel-containing self-assembled nanocochleates for treating pulmonary metastasis: An approach supporting pulmonary mechanics. ACS Biomaterials Science & Engineering. 2020 Dec 21;7(1):144-56.
Elsana H, Olusanya TO, Carr-Wilkinson J, Darby S, Faheem A, Elkordy AA. Evaluation of novel cationic gene based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Scientific reports. 2019 Oct 22; 9(1):15120.
Ghule MM, Bhoyar GS. Formulation and Evaluation of modified liposome for transdermal drug. Journal of Developing Drugs. 2018;7(1):2-3.
Oyungerel G, Batdemberel G, Munkhsaikhan G. Study of particle size in natural and technological water suspensions using photon cross correlation spectroscopy with Nanophox. Phys. Chem. 2020; 10:1-4.
Selvamani V. Stability studies on nanomaterials used in drugs. InCharacterization and biology of nanomaterials for drug delivery 2019 Jan 1 (pp. 425-444). Elsevier.
Ramasamy T, Khandasamy U, Hinabindhu RU, Kona K. Nanocochleate—a new drug delivery system. FABAD journal of pharmaceutical sciences. 2009 Mar; 34:91-101.
Çoban Ö, Değim Z, Yılmaz Ş, Altıntaş L, Arsoy T, Sözmen M. Efficacy of targeted liposomes and nanocochleates containing imatinib plus dexketoprofen against fibrosarcoma. Drug development research. 2019; 80(5):556-65.
Pawar AY. Nanocochleate: a novel drug delivery system. Asian Journal of Pharmaceutics (AJP). 2016;10(03).
Landge A, Pawar A, Shaikh K. Investigation of cochleates as carriers for topical drug delivery. Int. J. Pharm. Pharm. Sci. 2013 Mar; 5(2):314-20.
Perlin DS. Amphotericin B cochleates: a vehicle for oral delivery. Current Opinion in Investigational Drugs (London, England: 2000). 2004 Feb 1; 5(2):198-201.
Mali AJ, Joshi PA, Bothiraja C, Pawar AP. Fabrication and application of dimyristoyl phosphatidylcholine biomaterial-based nanocochleates dry powder inhaler for controlled release resveratrol delivery. Future Journal of Pharmaceutical Sciences. 2021 Dec; 7:1-2.
Poudel I, Ahiwale R, Pawar A, Mahadik K, Bothiraja C. Development of novel biotinylated chitosan-decorated docetaxel-loaded nanocochleates for breast cancer targeting. Artificial cells, nanomedicine, and biotechnology. 2018 Nov 5; 46(sup2):229-40.
Yücel Ç, Altintaş Y, Değim Z, Yılmaz Ş, Arsoy T, Altıntaş L, Çokçalışkan C, Sözmen M. Novel approach to the treatment of diabetes: Embryonic stem cell and insulin-loaded liposomes and nanocochleates. Journal of nanoscience and nanotechnology. 2019 Jul 1;19(7):3706-19.
Chen L, Yue B, Liu Z, Luo Y, Ni L, Zhou Z, Ge X. Study on the preparation, characterization, and stability of freeze-dried curcumin-loaded cochleates. Foods. 2022 Feb 28;11(5):710.
Jin T, Zarif L, Mannino R, inventors; University of Medicine, Dentistry of New Jersey, Biodelivery Sciences Inc, assignee. Nanocochleate formulations, process of preparation and method of delivery of pharmaceutical agents. United States patent US 6,153,217. 2000 Nov 28.
Published
Versions
- 2024-08-15 (2)
- 2024-08-15 (1)
How to Cite
Issue
Section
Copyright (c) 2024 Aparna Gajanan Vakhare, Vikrant P Vankhade, Sandip C Atram, Nishan N Bobade, Shrikant D Pande
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.